Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001181431-14-034312

President and CEO bought 16,000 shares at $6.32 ($101,120)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Anzalone Christopher Richard President and CEO 2014-10-15 Purchase +16,000 $6.32 $101,120 260,173 D: show line 1 in the form
Open-market purchases · 16,000 sh · avg $6.32 · $101,120
Loading xslF345X03/rrd417655.xml…